KRAS and P53 mutations and FDG-PET as a measure of glycolytic activity in metastatic non-small cell lung cancer patients.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9086-9086
Author(s):  
Seo-Hyun Kim ◽  
Ammar Karo ◽  
Sanjib Basu ◽  
Jeffrey Allen Borgia ◽  
Philip Bonomi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Small Cell ◽  
P53 Mutations ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Glycolytic Activity

scholarly journals Assessment of pulmonary 18 F-FDG-PET uptake and cytokine profiles in non-small cell lung cancer patients treated with radiotherapy and erlotinib

2017 ◽  
Vol 4 ◽  
pp. 57-63 ◽  
Author(s):  
Azadeh Abravan ◽  
Hanne Astrid Eide ◽  
Ingerid Skjei Knudtsen ◽  
Ayca Muftuler Løndalen ◽  
Åslaug Helland ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Cytokine Profiles

scholarly journals Comparison Between 18F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

2019 ◽  
Vol 61 (7) ◽  
pp. 990-998 ◽  
Author(s):  
Giovanni Rossi ◽  
Matteo Bauckneht ◽  
Carlo Genova ◽  
Erika Rijavec ◽  
Federica Biello ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
18F Fdg

Clinical outcome of cN0 non-small cell lung cancer patients staged by thin-slice CT, FDG-PET, and EBUS-TBNA.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 7052-7052
Author(s):  
Y. Sakairi ◽  
H. Hoshino ◽  
T. Nakajima ◽  
T. Fujiwara ◽  
F. Ishibashi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Outcome ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Fdg Pet ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Thin Slice
Sign in / Sign up

Export Citation Format

Share Document